Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: A meta-analysis and critical examination of current methodologies-Reference-Cited by-同舟云学术

Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: A meta-analysis and critical examination of current methodologies

Published:2014-01-31 Issue:6 Volume:83 Page:975-983
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Vardi Moshe¹,Novack Victor²,Pencina Michael J.¹³,Doros Gheorghe¹³,Burke David A.¹⁴,Elmariah Sammy¹⁵,Cutlip Donald E.¹⁴,Mauri Laura¹⁶,Yeh Robert W.¹⁵

Affiliation:

1. Harvard Clinical Research Institute; Boston Massachusetts

2. Soroka Clinical Research Center; Beer Sheva Israel

3. Department of Biostatistics; Boston University; Massachusetts

4. Cardiology Division; Beth Israel Deaconess Medical Center; Boston Massachusetts

5. Cardiology Division; Massachusetts General Hospital; Boston Massachusetts

6. Cardiology Division; Brigham and Women Hospital; Boston Massachusetts

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Reference34 articles.

1. Heart disease and stroke statistics-2012 update: A report from the American heart association;Roger;Circulation,2012

2. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: Data from the national health and nutrition examination survey 1999-2004;Ostchega;J Am Geriatr Soc,2007

3. Acc/aha 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American association for vascular surgery/society for vascular surgery, society for cardiovascular angiography and interventions, society for vascular medicine and biology, society of interventional radiology, and the acc/aha task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): Endorsed by the American association of cardiovascular and pulmonary rehabilitation; national heart, lung, and blood institute; society for vascular nursing; transatlantic inter-society consensus; and vascular disease foundation;Hirsch;Circulation,2006

4. Intermittent claudication. A risk profile from the Framingham heart study;Murabito;Circulation,1997

5. Inter-society consensus for the management of peripheral arterial disease (TASC II);Norgren;J Vasc Surg,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a prognostic model for 4 years risk of Peripheral arterial disease restenosis following endovascular therapy;2023-09-26

2. The study on the risk factors of restenosis after superficial femoral artery stenting;Vascular Investigation and Therapy;2023

3. Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization;Journal of the American College of Cardiology;2021-11

4. Mortality Rates After Paclitaxel-Coated Device Use in Patients With Occlusive Femoropopliteal Disease: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials;Journal of Endovascular Therapy;2021-06-09

5. Efficacy and Safety of a Novel Helical Self-Expanding Nitinol Stent for Femoropopliteal Artery Obliterans Disease;Annals of Vascular Surgery;2021-04